CHEMI SPA is a generic drug manufacturer focused on Oncology, Neurology.
CHEMI SPA's Key Drugs
CHEMI SPA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
CHEMI SPA's Recent FDA Approvals
New NDA/BLA approvals for CHEMI SPA over the last two years — novel drugs only, excluding generics and label supplements.
CHEMI SPA's Therapeutic Areas
CHEMI SPA's approved drugs and pipeline span 2 therapeutic areas, led by Oncology and Neurology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
CHEMI SPA's Top Competitors
CHEMI SPA's closest competitors by therapeutic-area and drug-target overlap include Pfizer, AbbVie, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
CHEMI SPA Pipeline Snapshot
Active clinical trials for CHEMI SPA across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2014-09-02
- Latest
- 2025-05-07
- Applications
- 4